What is EPKINLY?

EPKINLY is a treatment for people with certain types of diffuse large B-cell lymphoma (DLBCL) whose cancer has returned or didn't respond after 2 or more prior treatments. It's an immunotherapy called a bispecific antibody that is given as a subcutaneous injection, which means it's given under the skin.

Two people having breakfast.

How does EPKINLY work?

EPKINLY is a bispecific antibody that is designed to bind both T cells and B cells in the immune system at the same time. It is thought to work with your immune system to attack B cells.

Your immune system includes B cells and T cells.

Your immune system includes B cells and T cells.

In DLBCL, B cells can become cancerous. Cancerous B cells can grow uncontrollably.

In DLBCL, B cells can become cancerous. Cancerous B cells can grow uncontrollably.

EPKINLY is thought to work by binding to both T cells and B cells at the same time, helping T cells to attack B cells.

EPKINLY is thought to work by binding to both T cells and B cells at the same time, helping T cells to attack B cells.

""

Support when you need it

Dedicated support is available for you and your care partner. Get help with tracking symptoms, preparing for appointments, talking to your doctor, and finding information about financial support options.

Man and child playing with blocks.

Find out the results patients experienced on EPKINLY.